Compare Humana Inc (HUM) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Jumia Technologies AG - ADR — how do they compare? Humana Inc trades at $444.74 (market cap $46.49B), while Jumia Technologies AG - ADR trades at $6.53 (market cap $865.90M). The key difference: Humana Inc is far larger — about 53.7× Jumia Technologies AG - ADR's market cap, and Humana Inc pays a 0.91% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Jumia Technologies AG - ADR for 28 Days on average.
| HUM | JMIA | |
|---|---|---|
Market Cap | $46.49B | $865.90M |
Volume | 2,567,704 | 1,695,227 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $14.60 |
52-Week Low | $163.67 | $5.69 |
Typical Hold Time | 53 Days | 28 Days |
Enterprise Value | $53.84B | $831.54M |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
JMIA trades at $6.74, down 0.88% with bearish technical signals. The company shows improving fundamentals with revenue growth to $189M in 2025 and narrowing losses (-$62M net income). Recent $50M capital injection from IFC strengthens the balance sheet while management targets EBITDA breakeven by Q4 2026. Analyst consensus remains bullish with $12 price target despite recent earnings misses.
JMIA presents a turnaround story with operational improvements and path to profitability, but carries significant execution risk. The stock offers substantial upside to analyst targets if the company achieves its breakeven timeline, though persistent losses and competitive pressures remain concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
